What Caire does

Caire Health AI GmbH is a Munich-based health-AI company developing contactless vital-sign measurement software built on remote photoplethysmography (rPPG). Its core engine, VGo Core, processes standard webcam or smartphone video through proprietary deep-learning algorithms that detect subtle skin-color changes caused by blood flow to extract heart rate, respiration rate, blood pressure, and oxygen saturation in approximately 30 seconds, without wearables or additional hardware.

The company packages this engine into a four-product portfolio: VGo Clinical for hospital triage and vital-sign workflows, VGo Telemonitoring for remote patient monitoring and chronic disease management, VGo Drive for in-vehicle driver and passenger monitoring, and VGo Core as the underlying platform. The company is ISO 13485 certified, GDPR compliant, and pursuing EU AI Act compliance, and exposes HL7/FHIR integrations and APIs for embedding into hospital patient management and knowledge information systems.

Caire operates a B2B enterprise SaaS model selling through direct field sales with a 'Request Demo' motion and custom implementation plans. Customer segments span hospitals and clinics, remote patient monitoring providers, and automotive manufacturers. The company was founded in 2023, raised approximately €850K in a February 2025 funding round, and operates out of TUM Venture Labs with 1-10 employees.

Name

Caire

Legal name

Caire Health AI GmbH

Website

https://caire.ai

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

1–10 employees

Short description

Caire is a Munich-based health-AI company whose VGo platform uses remote photoplethysmography and deep learning to extract vital signs (heart rate, respiration, blood pressure, SpO2) from standard camera video, serving hospitals, remote patient monitoring providers, and automotive manufacturers through a B2B SaaS model.

Ownership category

akta.pro rank

Product category

Medical Device Software

NAICS

Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Software Publishers (5132)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI)

Keywords

• Contactless vital sign monitoring
• Remote photoplethysmography software
• Medical AI camera platform
• Remote patient monitoring
• Telemedicine vital measurement

Headquarters

HQ city

Munich

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Others, Marketing or Sales

Revenue model

1. Software as a Service (SaaS) Platform: Caire generates revenue through B2B SaaS licensing of its VGo Core technology platform to healthcare providers, hospitals, clinics, and automotive manufacturers. The model appears to be subscription-based with enterprise contracts that include custom implementation plans. Pricing is handled through direct sales demos rather than public pricing pages.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Caire develops and licenses AI-powered software (the VGo platform) that converts standard cameras into contactless medical-grade vital sign measurement tools. Using remote photoplethysmography and deep-learning algorithms, the software measures heart rate, respiration rate, blood pressure, and oxygen saturation from facial video in approximately 30 seconds, without wearables or additional hardware. The product family includes VGo Core (technology engine), VGo Clinical (hospital/clinic workflows), VGo Telemonitoring (home/remote monitoring), and VGo Drive (automotive), sold via enterprise B2B SaaS contracts.

Product overview

Caire offers a unified platform centered on its VGo Core technology engine, which powers multiple solution-specific products. The VGo Core technology transforms standard cameras into contactless health measurement tools using remote photoplethysmography (rPPG). The product portfolio includes VGo Clinical (for hospital and clinic workflows), VGo Telemonitoring (for remote patient monitoring at home), and VGo Drive (for automotive health monitoring). All solutions share the same core VGo engine while targeting different use cases and industry verticals.

Differentiator

Problem solved

Functional benefit

Brands

• VGo Core: The core technology engine that transforms ordinary cameras into powerful health measurement tools, delivering accurate vital sign measurements including heart rate, respiration, and blood pressure.
• VGo Clinical
• VGo Telemonitoring
• VGo Drive

Products and services

• VGo Core Core technology engine that transforms ordinary cameras into contactless health measurement tools, processing facial video through deep-learning algorithms to deliver heart rate, respiration rate, blood pressure, and oxygen saturation measurements in under 30 seconds without wearables or additional hardware. Serves as the foundation for Caire's clinical, telemonitoring, and automotive solutions.
• VGo Clinical Clinical software solution for hospitals and clinics that accelerates routine vital sign checks with contactless AI-powered measurements, reportedly reducing measurement process time by 83% and enabling staff to measure up to 4x faster than traditional methods. Integrates with Patient Management Systems (PMS) and Knowledge Information Systems (KIS) via HL7 and FHIR.
• VGo Telemonitoring Remote patient monitoring software enabling continuous, contactless health measurements for patients at home using only a standard camera, supporting chronic disease management, post-discharge monitoring, and preventive health with real-time vital sign tracking and medical alerts.
• VGo Drive Automotive software solution providing continuous vital signs monitoring of drivers and passengers in vehicles, supporting emergency detection and preventive care on the road without requiring additional hardware beyond in-vehicle cameras.

Quantifiable outcome

• 83% reduction in vital sign measurement time (from 3 minutes to 30 seconds per patient)
• +3 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

Scale indicators1 record

Recent moves6 records

Expansion highlights6 records

Direct peers

• Binah.ai: Israel-based company offering AI-powered contactless vital sign monitoring via standard cameras using rPPG technology. Most direct competitor to Caire, targeting insurance, wellness, and healthcare use cases with the same hardware-free value proposition.
• NuraLogix: Canadian company behind the Anura platform, which uses rPPG and deep learning to extract health metrics from facial video. Competes directly with Caire across consumer wellness, telehealth, and clinical research applications.
• FaceHeart: Taiwan-based startup commercializing rPPG-based remote vital sign measurement for healthcare and automotive driver monitoring. Closely aligned with Caire's product architecture and target verticals.
• Biobeat Technologies: Israel-based company offering remote patient monitoring solutions including AI-powered contactless and wearable vital sign measurement. Competes with Caire's VGo Telemonitoring product in the RPM and hospital-at-home markets.

Broad incumbents

• EarlySense: Israel-based established player in contact-free continuous patient monitoring for hospitals and post-acute care. While it uses different sensor technology (under-mattress ballistocardiography), it targets the same hospital workflow efficiency and RPM use cases as Caire.
• Preventice Solutions (Boston Scientific): US-based remote cardiac monitoring platform acquired by Boston Scientific. Provides continuous ambulatory ECG and connected health services, representing an established incumbent in the remote vital sign monitoring market where Caire's telemonitoring solution competes.
• iHealth Labs: US-based consumer health device manufacturer offering connected blood pressure monitors, glucose meters, and other vital sign devices. Represents the hardware-based incumbent model against which Caire's contactless software approach competes, particularly in remote patient monitoring.
• Withings: French connected health company offering smart scales, blood pressure monitors, sleep trackers, and other consumer health devices. Targets the same health-conscious consumer and remote monitoring segments as Caire via a hardware-led model.
• Vivify Health: US-based remote patient monitoring and chronic care management platform providing connected health kits and software. Targets the same RPM workflows and chronic disease management use cases as Caire's VGo Telemonitoring, but with a hardware-included delivery model.

Emerging players

• MindMaze: Swiss digital neurotherapeutics and AI health company with computer vision-based health assessment capabilities. While primarily focused on neurological recovery, its AI-driven health assessment pipeline overlaps with Caire's computer vision and AI capabilities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/healthcaire

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds2 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Caire